Your Treatment and Your Community: Advancing Evidence and Policy for Medical Products that Impact Others

On December 9, 2024, Duke-Margolis will present our refined viral transmission reduction framework alongside proposed policy reforms to improve evidence generation on indirect benefits and population health outcomes as well as leverage existing decision-making capacity by the U.S. Food and Drug...

On December 9, 2024, Duke-Margolis will present our refined viral transmission reduction framework...

Read More